17
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Physical management of depression in the elderly

&
Pages 417-426 | Published online: 11 Jul 2009

References

  • Abas M. A., Sahakian B. J., Levy R. Neuropsychological deficits and CT scan changes in elderly depressives. Psychological Medicine 1987; 20: 507–520
  • Abou-Saleh M. T., Coppen A. The prognosis of depression in old age: the case for lithium therapy. British Journal of Psychiatry 1983; 14(3)527–528
  • Alexoupoulos G. S., Shamoian C. J., Lucas J., et al. Medical problems of geriatric psychiatric patients and younger controls during electroconvulsive therapy. Journal of the American Geriatrics Society 1990; 32: 651–564
  • Altamura A. C., Percudani M., Guercetti G., Invernizzi G. Efficacy and tolerability of fluoxetine in the elderly: a double blind study versus amitriptyline. International Clinical Psychopharmacology 1984; 4: 103–106
  • Austin L. S., Arana G. W., Melvin J. A. Toxicity arising from lithium augmentation of antidepressant treatment in elderly patients. Journal of Clinical Psychiatry 1990; 5(1)344–345
  • Baldessarini R. J. Tricyclic anti-depressants. The Pharmacological Basis of Therapeutics8th edn, A. G. Oilman, L. S. Goodman, A. Oilman. Pergamon Press, New York 1989; 409–410
  • Baldwin R. C. Delusional and non-delusional depression in late life: evidence for distinct subtypes. British Journal of Psychiatry 1988; 15(2)39–44
  • Baldwin R. C. Depressive illness. Psychiatry in the Elderly, R. Ja-Coby & C. Oppenheimer. Oxford University Press, Oxford 1990
  • Ball J. R. B., Kiloh L. G. A controlled trial of imipramine in treatment of depressive states. British Medical Journal 1991; 2: 1052–1054
  • Ballard C. G., Mohan R. N. C., Handy S., Dod-Well D. Medication compliance and dispensing among psychogeriatric patients. Psychiatric Bulletin 1991; 1(5)624–625
  • Beaumont G. Duration and dose in depression. Psychiatry in Practice 1993; 1: 24
  • Bekker F. M., van Marwijk H. W., Nolen W. A., et al. Lithium in the treatment of depressed elderly patients. Nederlands Tidjschrift voor Geneeskunde 1959; 134: 442–445
  • Benbow S. M. The use of electroconvulsive therapy in old age psychiatry. International Journal of Geriatric Psychiatry 1990; 2: 25–30
  • Benbow S. M. The role of electroconvulsive therapy in the treatment of depressive illness in old age. British Journal of Psychiatry 1989; 15(5)147–152
  • Benbow S. M. ECT in late life. International Journal of Geriatric Psychiatry 1987; 6: 401–406
  • Benetello P., Furlanutj M., Zara G., Baraldo M. Imipramine pharmakokinetics in depressed geriatric patients. International Journal of Pharmacology Research 1990; 10: 191–195
  • Blazer D. The diagnosis of depression in the elderly. Journal of the American Geriatric Society 1980; 2(8)52–58
  • Bougerol T., Uchida C., Gachoud J. P., et al. Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM IH). Psychopharmacology 1991; 106(suppl.)S102–S108
  • Bramble D. A survey of lithium use in the elderly. International Journal of Geriatric Psychiatry 1992; 7: 819–826
  • Brandon S., Cowley P., McDonald C., et al. Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. British Medical Journal 1992; 288: 22–25
  • Butler R. N. Psychiatry and the elderly: an overview. American Journal of Psychiatry 1975; 13(2)893–900
  • Cohn C. K., Shrivastava R., Mendels J., et al. Double blind multicenter comparison of sertraline and amitriptyline in elderly depressed patients. Journal of Clinical Psychiatry 1984; 51(51)28–33
  • Crow T. J., Deakin J. F. W., Johmstone E. C., et al. The Northwick Park ECT trial: predictors of response to real and simulated ECT. British Journal of Psychiatry 1990; 144: 227–237, Current Problems IN Pharmacovigilance (1993) Dystonia and withdrawal symptoms with paroxetine, 19, February.
  • De Vanna M., Kummer J., Agnoli A., et al. Moclobemide compared with second-generation antidepressants in elderly people. Acta Psychiatrica Scandinavica 1984; 82/360(suppl)64–66
  • Doogan D., Calliard V. Sertraline in the prevention of depression. British Journal of Psychiatry 1992; 160: 217–220
  • Dorman T. A. Toxicity of tricyclic anti-depressants: are there important differences?. Journal of International Medical Research 1990; 13: 77–83
  • Dorman T. A. (1985) A double blind comparison of paroxetine and mianserin on sleep in elderly depressed hospital patients. Paper presented at the 17th Collegium Internationale Neuro-Psychopharma-cologium, Kyoto, 1990
  • Dornseif B. E., Dunlop S. R., Potvin J. H., Wer-Nicke J. F. Effect of dose escalation after low-dose fluoxetine therapy. Psychopharmacology Bulletin 1989; 2(5)71–79
  • Eccleston D. L-Tryptophan and depressive illness: a valuable adjunct to therapy?. Psychiatric Bulletin 1990; 17: 223–224
  • Fawcett J., Zajecka J. M., Kravttz H. M., et al. Fluoxetine versus amitriptyline in adult outpatients with major depression. Current Therapeutic Research 1993; 45: 821–832
  • Feighner J. P., Cohn J. B. Double-blind comparative trails of fluoxetine and doxepin in geriatric patients with major depressive disorder. Journal of Clinical Psychiatry 1985; 4(6)20–25
  • Feighner J. P., Boyer W. F., Meredith C. H., Hendrickson G. An overview of fluoxetine in geriatric depression. British Journal of Psychiatry 1988; 153(suppl. 3)105–108
  • Ferrier I. N., Silverstone T., Ecclestone D. Selective serotonin re-uptake inhibitors: use in depression. Psychiatric Bulletin 1992; 1(6)737–739
  • Finnegan K. T., Gabiola J. M. Fluoxetine overdose. Letter to the editor. American Journal of Psychiatry 1988; 14: 5, p. 1604.
  • Fisch C. Effects of fluoxetine on the electrocardiogram. Journal of Clinical Psychiatry 1985; 4(6)42–44
  • Flint A. J. The optimum duration of anti-depressant treatment in the elderly. International Journal of Geriatric Psychiatry 1989; 1: 617–619
  • Foster J. R., Gershell W. J., Goldfarb A. I. Lithium treatment in the elderly. Journal of Gerontology 1977; 3(2)299–302
  • Foster J. R., Silver M., Boskay I. J. E. The potential use of adjunctive erythrocyte lithium levels in detecting serious impending neurotoxicity in the elderly: two case reports. International Journal of Geriatric Psychiatry 1992; 5: 9–14
  • Fraser R. M., Glass I. B. Recovery from ECT in elderly patients. British Journal of Psychiatry 1978; 13(3)524–528
  • Fraser R. M., Glass I. B. Unilateral and bilateral ECT in elderly patients: a comparative study. Acta Psychiatrica Scandinavica 1980; 6(2)13–31
  • Friedman J. R., Norman D. C., Yoshikawa T. T. Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly. Journal of American Geriatric Society 1989; 3(7)145–149
  • Gerner R. H. Present status of drug therapy of depression in late life. Journal of Affective Disorders 1990; 1(suppl 6)S23–S31
  • Guelfi J. D., Payan C., Fermanian J., et al. Moclobemide versus clomipramine in endogenous depression: a double-blind randomised clinical trial. British Journal of Psychiatry 1985; 160: 519–524
  • Halikas J. Two combined, multicentre, doxepin-controlled, double blind studies of paroxetine in geriatric depressed outpatients. Presented at 5th World Congress of Biological Psychiatry, June, Florence. 1992
  • Henry J. A., Antao C. A. Suicide and fatal antidepressant poisoning. European Journal of Medicine 1991; 1: 343–348
  • Jefferson J. W. Lithium and affective disorder in the elderly. Comprehensive Psychiatry 1983; 2(4)166–178
  • Johnstone E. C., Deakin J. F. W., Lawler P., et al. The Northwick Park electroconvulsive therapy trial. Lancet 1992; ii: 1317–1320
  • Kendell R. E. The present status of electroconvulsive therapy. British Journal of Psychiatry 1981; 13(9)265–283
  • Kramer B. A. Out-patient electroconvulsive therapy: a cost saving alternative. Hospital and Community Psychiatry 1990; 4(1)361–363
  • Kushnir S. L. Lithium-antidepressant combination in the treatment of physically ill geriatric patients. American Journal of Psychiatry 1986; 14(3)378–379
  • Lader M., Herrington R. Biological Treatments in Psychiatry. Oxford University Press, Oxford 1980; 327
  • Lehman H. E. Recognition and treatment of depression in geriatric patients. Clinical Depressions: diagnostic and therapeutic challenges, F. J. Ayd. Ayd Medical Communications, Baltimore, MD 1990
  • Lindesay J., Murphy E. Dementia, depression and subsequent institutionalization: the effect of home support. International Journal of Geriatric Psychiatry 1980; 4: 3–9
  • Masterton G., Warner M., Roxburgh B. Supervising lithium: a comparison of a lithium clinic, psychiatric out-patient clinic and general practice. British Journal of Psychiatry 1989; 152: 535–538
  • Mindham R. H. S., Bagshaw A., Rowland C., Shephard M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychological Medicine 1988; 3: 5–17
  • Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979; 13(4)382–389
  • Montgomery S. A. Clinical significance of 5-HT uptake inhibitors. Human Psychopharmacology 1973; 6: S3–S7
  • Morris J. The need to consider quality of life as an outcome of antidepressant therapy. Psychiatric Bulletin 1991; 1(5)723–724
  • Murray G. B., Shea V., Conn D. K. Electroconvulsive therapy in poststroke depression. Journal of Clinical Psychiatry 1986; 4(7)258–260
  • Nelson J. C., Mazure C., Quinlan D. M., Jatlow P. I. Drug responsive symptoms in melancholia. Archives of General Psychiatry 1984; 4(1)663–638
  • Newsom-Smith J. G. B., Hirsch S. R. Psychiatric symptoms in self-poisoning patients. Psychological Medicine 1991; 9: 493–500
  • Nimh/Nih Consensus Development Conference Statement. Mood disorders: pharmacologic prevention of recurrence. American Journal of Psychiatry 1979; 142: 469–476
  • Old Age Depression Interest Group (OAD1G). How long should the elderly take anti-depressants? A double blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry 1993; 16(2)175–182
  • Phanjoo A. L., Wonnacott S., Hodgson A. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatrica Scandinavica 1991; 8(3)476–479
  • Pippard J., Ellam L. Electroconvulsive Therapy in Great Britain, 1980. Gaskell/Royal College of Psychiatrists, London 1985
  • Prien R. F., Kupffer D. J. Continuation drug therapy for major depressive episodes: how long should it be maintained?. American Journal of Psychiatry 1981; 143: 18–23
  • Salzman C. Electroconvulsive therapy in the elderly patient. Psychiatric Clinics of North America 1986; 5: 191–197
  • Schou M. Lithium and treatment resistant depressions: a review. Lithium 1982; 1: 3–8
  • Scott A. I. F. Which depressed patients will respond to electroconvulsive therapy? The search for biological predictors of recovery. British Journal of Psychiatry 1989; 15(4)8–17
  • Scott A. I. F., Whalley L. J. The rate of onset of the antidepressant effect of electro-convulsive therapy: a neglected topic of research. British Journal of Psychiatry 1993; 16(2)725–732
  • Seth R., Jennings A. L., Bindman J., et al. Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. British Journal of Psychiatry 1990; 161: 562–565
  • Shulman K., Post F. Bipolar affective disorder in old age. British Journal of Psychiatry 1980; 13(6)26–32
  • Siegfried K., Connolly M. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression. International Clinical Psychopharmacology 1992; 1: 231–243
  • Song F., Freemantle N., Sheldon T. A., et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal 1986; 306: 683–687
  • Stoudemire A., Knos G., Gladson M., et al. Labetalol in the control of cardiovascular responses to electroconvulsive treatment in high risk depressed medical patients. Journal of Clinical Psychiatry 1993; 51: 508–512
  • Stroudmire A., Hill C. D., Morris R., et al. Cognitive outcome following tricyclic and electro-convulsive treatment of major depression in the elderly. American Journal of Psychiatry 1990; 148: 1336–134Q
  • Thompson T. L., Moran M. G., Nies A. S. Psychotropic use in the elderly. New England Journal of Medicine 1983; 30(8)194–199
  • Tiller J., Maguire K., Davies B. A sequential double-blind controlled study of moclobemide and mianserin in elderly depressed patients. International Journal of Geriatric Psychiatry 1991; 5: 199–204
  • Weiner R. D. The role of electroconvulsive therapy in the treatment of depression in the elderly. Journal of the American Geriatrics Society 1982; 30: 710–712
  • Wernicke J. F. The side effect profile and safety of fluoxetine. Journal of Clinical Psychiatry 1985; 4: 59–6
  • West E. D. Electroconvulsive therapy in depression: a double blind controlled trial. British Medical Journal 1981; 28(2)355–357
  • Yassa R., Nastase C., Dupont D., Thibeau M. Tardive dyskinesia in elderly psychiatric patients. American Journal of Psychiatry 1992; 14(9)1206–1211
  • Zimmer B., Rosen J., Thornton J. E., et al. Adjunctive lithium carbonate treatment in nortriptyline-resistant elderly depression. Journal of Clinical Psychopharmacology 1990; 11: 254–256
  • Zis A. P., Grof P., Webster M., et al. Prediction of relapse in recurrent affective disorder. Psychopharmacology Bulletin 1991; 16: 47–49

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.